Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: Results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up

  1. Wirth, M.
  2. Tyrrell, C.
  3. Delaere, K.
  4. Sánchez-Chapado, M.
  5. Ramon, J.
  6. Wallace, D.M.A.
  7. Hetherington, J.
  8. Pina, F.
  9. Heyns, C.F.
  10. Navani, S.
  11. Armstrong, J.
Aldizkaria:
Prostate Cancer and Prostatic Diseases

ISSN: 1365-7852,  1476-5608

Argitalpen urtea: 2007

Alea: 10

Zenbakia: 1

Orrialdeak: 87-93

Mota: Artikulua

DOI: 10.1038/SJ.PCAN.4500916 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus